← Back

Wire · opportunities

Medtronic's $700M Strategic Investment in Cornerstone Robotics: Global Soft Tissue ...

Published

3 September 2026

Topic

opportunities

Sectors

Healthtech Infrastructure

Geography

Asia-Pacific

Source

Read at healthcare.digital

Verified

Fusion42 · 4 September 2026 · Fusion42 review

Medtronic announced a $700 million strategic investment in Cornerstone Robotics, securing exclusive rights to distribute Cornerstone’s Sentire soft-tissue robotic surgery system outside the U.S., accelerating their expansion in international markets including China, the EU, and Singapore.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 2 sources have reported it.

◆ The Wire takeaway

Medtronic’s dual platform bet changes competitive stakes for surgical robotics outside the U.S. You need to rethink partnerships or sales strategies to address both high-end academic buyers and price-sensitive hospitals now open to new entrants.

Coverage

2 sources · 3 Sep 2026

Related on Wire

Topics

Healthtech Infrastructuremedtronicrobotic-assisted-surgerystrategic-investmentinternational-expansionsurgical-robotics